Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Subpart IVF - Clinical – Hematologic
from Part IV - Clinical
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 244 - 256Publisher: Cambridge University PressPrint publication year: 2017
References
References
Shapiro, B. Benjamin, LJ, Payne, R, Heidrich, G. Sickle cell-related pain: Perceptions of medical practitioners. J Pain Symptom Manage 1997;14(3):168–174.CrossRefGoogle ScholarPubMed
Conran, N, Franco-Penteado, CF, Costa, FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33(1):1–16.CrossRefGoogle ScholarPubMed
Rupp, T, Delaney, K. Inadequate analgesia in emergency medicine. Annals of Emergency Medicine. 2004;43(4):494–503.CrossRefGoogle ScholarPubMed
Brookoff, D, Polomano, R. Treating sickle cell pain like cancer pain. Annals of Internal Medicine. 1992;116(5):364–368.CrossRefGoogle ScholarPubMed
Roseff, SD, Sickle cell disease: a review. Immunohematology/American Red Cross. 2009;25(2):67–74.Google ScholarPubMed
McClish, D, Smith, WR, Dahman, BA, et al. Pain site frequency and location in sickle cell disease: the PiSCES project. Pain. 2009:145(1–2):246–251.CrossRefGoogle ScholarPubMed
Platt, O, Thorington, BD, Brambilla, DJ, et al. Pain in sickle cell disease – rates and risk factors. NEJM. 1991;325:11–16.CrossRefGoogle ScholarPubMed
Ballas, SK, Gupta, K, Adams-Graves, P. Sickle cell pain: A critical reappraisal. Blood. 2012;120(18):3647–3656.CrossRefGoogle Scholar
Taylor, LEV, Scotts, NA, Jumphreys, J, et al. A review of the literature on multiple dimensions of chronic pain in adults with sickle cell disease. Journal of Pain and Symptom Management. 2010;40(3): 416–435.CrossRefGoogle ScholarPubMed
Drookoff, D, Polomano, R. Treating sickle cell pain like cancer pain. Annals of Internal Medicine. 1992;116(5):364–368.CrossRefGoogle Scholar
Waldrop, R, Mandry, C. Health professional perceptions of opioid dependence among patients with pain. American Journal of Emergency Medicine. 1995;13(5):529–531.CrossRefGoogle ScholarPubMed
Smith, WR, Jordan, LB, Hassel, KL. Frequently asked questions by hospitalist managing pain in adults with sickle cell disease. Journal of Hospital Medicine. 2011; 6:297–303.CrossRefGoogle ScholarPubMed
Yawn, BP, Buchanan, GR, Afenyi-Annan, AN, et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048.CrossRefGoogle Scholar
Ballas, SK. The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin. 1995;19(6) 323–333.CrossRefGoogle ScholarPubMed
Haywood, C, Beach, MC, Lanzkron, S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. Journal of the National Medical Association. 2009;101(10):1022–1033.CrossRefGoogle ScholarPubMed
Labbe, E, Herbert, D, Haynes, J. Physician’s attitude and practices in sickle cell disease pain management. J Palliative Care. 2005;21:246–251.CrossRefGoogle ScholarPubMed
Friedman, EW, Webber, AB, Osborn, HH, et al. Oral analgesia for treatment of painful crisis in sickle cell anemia. Ann Emergency Medicine. 1986;15:783–791.CrossRefGoogle ScholarPubMed
Silbergleit, R, Jancis, MO, McNamara, RM. Mangement of sickle cell pain crisis in the emergency department at teaching hospitals. Journal of Emergency Medicine. 1999;17(4):625–630.CrossRefGoogle Scholar
Benjamin, LJ, Dampier, CD, Jacox, AK, et al. Guidelines for the management of acute and chronic pain in sickle-cell disease. APS Clinical Practice Guideline Series, No. 1, 1999.Google Scholar
Solomon, LR. Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void. Blood 2008; 111:997–1003.CrossRefGoogle ScholarPubMed
Evidence-Based Management of Sickle Cell Disease: Expert Panel Report. 2014; Available from: https://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines.Google Scholar
Melzer-Lange, MD, Walsh-Kelly, C, Lea, G, et al. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. 2004;20(2):2–4.Google Scholar
Rees, DC, Olujohungbe, AD, Parker, NE, et al. Guidelines for the management of the acute painful crisis in sickle cell disease. British Journal of Hematology. 2003;120(5):744–752.CrossRefGoogle ScholarPubMed
Lyon, M, Sinclair, D, Renwick, E. Comparison of outcomes before and after implementation of an observation unit clinical pathway for sickle cell vaso-occlusive crisis. Florida Journal of Sickle Cell Disease and Hemoglobinopahty. 2010. 4(1):19.Google Scholar
References
Carson, JL, Grossman, BJ, Kleinman, S, et al. Red Blood cell transfusion: a clinical practice guideline from the AABB. Ann Int Med 2012; 157(1):49–58.CrossRefGoogle Scholar
National Health and Medical Research Council and the Australasian Society of Blood Transfusion. Clinical practice guidelines on blood product utilization [online text]. 2001. Available at: www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp78.pdf?q=publications/synopses/_files/cp78.pdf. Accessed February 20, 2016.Google Scholar
Guidelines for the clinical use of red cell transfusions. British J Haematol, 2001;113: 24–31.CrossRefGoogle Scholar
Viele, MK, Weiskopf, RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah’s Witnesses. Transfusion 1994; 43: 396–401.CrossRefGoogle Scholar
Liumbruno, G, Bennardello, F, Lattanzio, A, et al. Recommendations for the transfusion of red blood cells. Blood Transfus 2009, 7:49–64.Google ScholarPubMed
Choo, Y. The HLA system in transfusion medicine. In: McCullough, J, ed. Transfusion Medicine. New York, NY: McGraw–Hill Book Co;1998:401.Google Scholar
Castro, O. Management of sickle-cell disease: recent advances and controversies. Br J Haematology. 1999; 107: 2–11.CrossRefGoogle Scholar
British Committee for Standards in Haematology. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. The British Society for Haematology, 2004; 126: 11–28.CrossRefGoogle Scholar
American Red Cross. Practice Guidelines for Blood Transfusions [online text]. 2nd ed. 2007. Available at: www.redcross.org/www-files/Documents/WorkingWiththeRedCross/practiceguidelinesforbloodtrans.pdf. Accessed January 5, 2012.Google Scholar
Baker, RI, Coughlin, PB, Gallus, AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. MJA 2004; 181: 492–497.Google Scholar
Baker, RI, Coughlin, PB, Gallus, AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis andHaemostasis. MJA 2004; 181: 492–497.Google Scholar
Cushman, M, Lim, W, Zakai, N. American Society of Hematology: Clinical Practice Guide on Anticoagulant Dosing and Management of Anticoagulant-Associated Bleeding Complications in Adults [online text]. 2011. Available at: www.hematology.org/Practice/Guidelines/7243.aspx. Accessed February 20, 2016.Google Scholar
World Federation of Hemophilia. Guidelines for the Management of Hemophilia [online text]. 2013. Available at: www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf. Accessed February 20, 2016.Google Scholar
National Hemophilia Foundation. Medical and Scientific Advisory Council Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders [online text]. 2015. Available at: www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=693. Accessed February 20, 2016.Google Scholar
Ansell, JE. 9th National Conference on Anticoagulant Therapy. Preface. J Thromb Thrombolysis 2008; 25:1.CrossRefGoogle ScholarPubMed
Mannucci, PM. Treatment of von Willebrand’s Disease. N Engl J Med 2004;351:683–694.CrossRefGoogle ScholarPubMed
National Heart, Lung, and Blood Institute The-Diagnosis-Evaluation-and-Management-of-von-Willebrand-Disease- [online text]. 2008. Available at: http://catalog.nhlbi.nih.gov/catalog/product/The-Diagnosis-Evaluation-and-Management-of-von-Willebrand-Disease-Full-Report-/08-5832. Accessed February 20, 2016.Google Scholar
American Society of Hematology: Clinical Practice Guideline on the Evaluation and Management of von Willebrand Disease [online text]. 2012. Available at: www.hematology.org/practice/guidelines/426.aspx. Accessed February 20, 2016.Google Scholar
British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. The British Society for Haematology, 2003; 122: 10–23.CrossRefGoogle Scholar
Slichter, SJ. Evidence-based platelet transfusion guidelines. American Society of Hematology Education Book. 2007;1:172–178.Google Scholar
American Society of Hematology: Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia [online text]. 2011. Available at: www.hematology.org/Practice/Guidelines/6584.aspx. Accessed February 20, 2016.Google Scholar
Cines, DB, Blanchette, VS. Immune Thrombocytopenic Purpura. N Engl J Med 2002; 346:995–1008.CrossRefGoogle ScholarPubMed
McCullough, J, Refaai, MA, Cohn, CS. Blood Procurement and Red Cell Transfusion. In: Kaushansky K, Lichtman MA, Prchal JT, et al. eds. Williams Hematology. 9th ed. New York: McGraw-Hill; 2016, chapter 138. www.accessmedicine.com.library.ccf.org/content.aspx?aID=6236286. Accessed February 20, 2016.Google Scholar
Vigue, B. Bench-to-bedside review: Optimizing emergency reversal of Vitamin K antagonists in severe haemorrhage – from theory to practice. Crit Care 2009; 13: 209.CrossRefGoogle Scholar